Related Experiment Video
Updated: Sep 29, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
[Haemophilus influenzae type a as the causative agent of meningitis in an infant]
D C Mulder1, R D Padberg, M Westra
1Afd. Kindergeneeskunde, Zaans Medisch Centrum, Koningin Julianaplein 58, 1502 DV Zaandam.
Insights
Haemophilus influenzae type b vaccination has reduced type b infections but may increase type a invasive infections. A case of meningitis caused by H. influenzae type a highlights this emerging public health concern.
Area of Science:
- Pediatrics
- Infectious Diseases
- Vaccinology
Background:
- The widespread use of conjugated Haemophilus influenzae type b (Hib) vaccine has dramatically reduced invasive Hib infections.
- Hib vaccination is not known to provide cross-protection against other Hib serotypes.
Observation:
- A fully vaccinated 6-month-old infant developed meningitis due to Haemophilus influenzae type a (Hia).
- This case represents one of the few reported Hia infections in the Netherlands since 1975.
Findings:
- Invasive infections caused by H. influenzae type b have significantly declined post-vaccination introduction.
- Non-type b H. influenzae, including Hia, may experience increased carrier rates and invasive infections due to reduced competition from Hib.
Implications:
- The success of Hib vaccination may inadvertently lead to a rise in invasive infections caused by non-vaccine serotypes like Hia.
- Enhanced surveillance for non-type b H. influenzae invasive infections is crucial following widespread Hib vaccination programs.
Abstract:
A 6-month-old girl had been ill with a cold for several days and was increasingly drowsy. She had been fully vaccinated against Haemophilus influenzae type b and had meningitis due to H. influenzae type a. She made a complete recovery after treatment with ceftriaxone and amoxicillin. In the Netherlands, vaccination with the conjugated H. influenzae type b vaccine was started in 1993 and since then invasive infections caused by H. influenzae type b have almost disappeared. Vaccination may suppress carriership of H. influenzae type b. However, vaccination does not elicit cross-protective antibodies against other serotypes of H. influenzae. H. influenzae non-type b may profit from the vaccination state, resulting in a higher carrier rate and an increased incidence of invasive infections. In the Netherlands, H. influenzae type a as the causative agent of an invasive infection has been recorded for the first time since registration started in 1975 and since then five such cases have been reported. In the literature, 45 cases of infection with H. influenzae type a have been described up until now.
More Related Videos
10:47Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
Influenza
Encephalitis l: Introduction